Your Complete Wegovy vs Mounjaro Switching Guide
Why Patients Consider Switching: Wegovy vs Mounjaro Cost UK Analysis
The decision to switch between GLP-1 treatments often centres on cost considerations, with Wegovy vs Mounjaro cost UK comparisons revealing significant price variations across different doses. Wegovy (semaglutide) functions as a single GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist, representing different mechanisms despite similar weight management outcomes. Patients frequently switch due to side effect tolerability, cost pressures, or availability issues with their current treatment. Our GPhC-registered pharmacy (#9012878) supports both medications, ensuring continuity of care during any transition period.
Switching between these prescription-only medicines requires careful prescriber oversight to ensure safety and efficacy. The dose escalation schedules differ between treatments, making professional guidance essential for determining equivalent starting doses. Cost considerations become particularly relevant during maintenance phases, where long-term treatment expenses accumulate significantly. EverydayMeds provides transparent pricing for both options, enabling informed financial planning for your weight management journey.
Wegovy vs Mounjaro Cost UK: Complete Pricing Breakdown
Our Wegovy pricing structure begins at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £269.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning customers use code DOSE25 to access these competitive rates. The dose escalation protocol spans 16 weeks before reaching maintenance, with total initiation costs varying based on individual tolerance and progression speed. Bundle options provide convenience for patients planning extended treatment periods, eliminating the need for frequent reordering.
Mounjaro pricing follows a different structure due to its unique dose escalation schedule and dual-mechanism formulation. When comparing Wegovy vs Mounjaro cost UK implications over 12 months, maintenance dose pricing becomes the primary financial consideration. Our clinical team can provide personalised cost projections based on your likely maintenance dose and treatment duration. Both treatments represent significant investments in long-term health, with potential cost savings through our bundle packages and loyalty discount codes.
Clinical Evidence: Understanding Wegovy vs Mounjaro Cost UK Value
Wegovy's clinical evidence stems from the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, as documented by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events, adding significant clinical value beyond weight management alone. These results inform the cost-effectiveness analysis when evaluating Wegovy vs Mounjaro cost UK considerations.
Both treatments underwent rigorous clinical testing with different trial designs and patient populations, making direct comparison of weight loss percentages inappropriate without clinical context. Your prescriber will consider individual factors including medical history, previous treatment responses, and cost implications when recommending the most suitable option. The clinical evidence supports both treatments as effective weight management tools when used appropriately under medical supervision.
How Wegovy Works: Understanding Your Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines after eating. This mechanism targets appetite centres in the brain, promoting feelings of fullness and reducing food cravings throughout the day. The weekly injection provides sustained hormone levels, supporting consistent appetite control between doses. Unlike rapid-acting appetite suppressants, Wegovy's effects develop gradually during the dose escalation phase, allowing your body to adapt naturally. The 16-week escalation protocol minimises side effects whilst optimising therapeutic benefits, justifying the investment in this sophisticated treatment approach.
EverydayMeds Ordering Process: Seamless Treatment Switching
Our streamlined ordering process begins with a comprehensive 3-minute online clinical assessment, capturing your medical history, current medications, and treatment goals. Qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection and dose recommendations. Once approved, your Wegovy ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for medication stability. Switching patients receive additional support regarding dose conversion and timing between treatments. Our pharmacy team coordinates with your current prescriber when necessary, ensuring seamless treatment transitions without gaps in care.
Storage Advantages: Wegovy vs Mounjaro Cost UK Practical Benefits
Wegovy offers superior storage flexibility compared to Mounjaro, maintaining stability for 6 weeks at room temperature below 30°C versus Mounjaro's 21-day limit. This storage advantage reduces medication waste during travel or temporary fridge failures, protecting your investment in treatment. The FlexTouch pen design provides precise dose delivery with clear visual confirmation of injection completion. Refrigerated storage at 2-8°C before first use ensures maximum potency throughout the treatment period. Proper storage practices directly impact treatment effectiveness and cost-efficiency, making Wegovy's extended temperature tolerance particularly valuable for busy lifestyles.
Switching Protocols: Safe Wegovy vs Mounjaro Cost UK Transitions
Patients switching from Mounjaro to Wegovy typically begin with careful dose conversion calculations based on their current tirzepatide dose and individual response patterns. The different mechanisms of action may require adjustment periods, with some patients experiencing temporary changes in appetite control during transition. Your prescriber will determine appropriate washout periods and starting doses to minimise disruption to your weight management progress. EverydayMeds coordinates timing between final Mounjaro doses and first Wegovy injections, ensuring optimal treatment continuity.
Cost considerations during switching include potential overlapping prescription charges and dose adjustment periods that may extend the escalation phase. Our bundle packages can provide cost predictability during transition periods, whilst our clinical team monitors progress and adjusts recommendations accordingly. The switch process typically takes 4-6 weeks to complete, with most patients achieving stable appetite control on their new regimen within this timeframe.
Making Your Wegovy vs Mounjaro Cost UK Decision
Your final treatment choice should balance clinical suitability, cost implications, and practical considerations including storage requirements and injection preferences. Both Wegovy and Mounjaro are available from EverydayMeds, with our prescribers helping determine the most appropriate option based on your individual circumstances. The switching process requires medical supervision to ensure safety and efficacy throughout the transition period. Our competitive pricing structure, combined with discount codes FIRST40 for new customers and DOSE25 for returning patients, makes either treatment option accessible and affordable. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and explore both treatment options with expert guidance from our qualified medical team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
